Company Search:
Advanced Search
Sponsored Links
UCB Sa Company Snapshot
UCB Sa operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares UCB Sa with three other pharmaceutical manufacturers in Europe: Lonza Group AG of SWITZERLAND (2020 sales of 4.51 billion Swiss Francs [US$4.87 billion] of which 99% was Pharma&Biotech), Biomerieux SA of FRANCE (3.12 billion Euros [US$3.64 billion] of which 85% was Diagnostic Clinical Equipment), and Grifols SA which is based in SPAIN (5.34 billion Euros [US$6.24 billion] of which 79% was Bioscience).

Sales Analysis. During the second quarter of 2021, sales at UCB Sa totalled 2.78 billion Euro. This is an increase of 6.5% from the 2.61 billion Euro in sales at the company during the second quarter of 2020. UCB Sa reported sales of 5.35 billion Euro (US$6.25 billion) for the year ending December of 2020. This represents an increase of 8.8% versus 2019, when the company's sales were 4.91 billion Euro. Sales at UCB Sa have increased during each of the previous five years (and since 2015, sales have increased a total of 38%). Sales of Briviact saw an increase that was more than double the company's growth rate: sales were up 30.3% in 2020, from 221.00 million Euro to 288.00 million Euro. Not all segments of UCB Sa experienced an increase in sales in 2020: sales of Other Products fell 18.6% to 358.00 million Euro. UCB Sa also experienced decreases in sales in Neupro (down 2.5% to 311.00 million Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for UCB Sa
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): 92.30
(Figures in Euros )
1 Week 1.2%   13 Weeks -6.8%  
4 Weeks 8.4%   52 Weeks -6.8%  
UCB Sa Key Data:
  Ticker: UCB Country: Belgium
  Exchanges: BRU Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 5,347,000,000
(Year Ending Jan 2021).
Employees: 8,409
  Currency: Euros Market Cap: 17,427,307,634
  Fiscal Yr Ends: December Shares Outstanding: 188,811,567
  Share Type: Actions Ordinaires Closely Held Shares: 73,819,519
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.